FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30037111000001101: Pembrolizumab (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    93619501000001110 Pembrolizumab (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    93619601000001114 Pembrolizumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Pembrolizumab Is a Virtual therapeutic moiety false Inferred relationship Existential restriction modifier
    Pembrolizumab Is a Product containing monoclonal antibody false Inferred relationship Existential restriction modifier
    Pembrolizumab Has active ingredient Monoclonal antibody false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Pembrolizumab 50mg powder for solution for infusion vials Is a False Pembrolizumab Inferred relationship Existential restriction modifier
    Pembrolizumab 100mg/4ml solution for infusion vials Is a False Pembrolizumab Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start